1. Mateon Therapeutics Mateon Therapeutics United States says:

    Max Planck Institute's data on Artemisinin is in agreement with our previously reported SARS-COV-2 antiviral activity of purified Artemisinin vs. Artemesia extract.  Based on the in vitro data and anectodal clinical data we have launched a global interventional study to evaluate the Artemisinin versus COVID-19.  The drug product was also approved by India's AYUSH ministry.

    investor.mateon.com/.../mateon-announces-first-patient-enrolled-arti-19-multicenter

    investor.mateon.com/.../mateon-therapeutics-initiate-commercialization-artishieldtm

    We encourage collaboration among the various stakeholders to quickly arrive at a cure for COVID-19.

    Regards
    Vuong Trieu PhD
    CEO/Mateon Therapeutics

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.